BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vaccaro V, Sperduti I, Vari S, Bria E, Melisi D, Garufi C, Nuzzo C, Scarpa A, Tortora G, Cognetti F, Reni M, Milella M. Metastatic pancreatic cancer: Is there a light at the end of the tunnel? World J Gastroenterol 2015; 21(16): 4788-4801 [PMID: 25944992 DOI: 10.3748/wjg.v21.i16.4788]
URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4788.htm
Number Citing Articles
1
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Philippe Bourget, Jérôme Cros, Anne Couvelard, Alain Sauvanet, Marie-Pierre Vullierme, Christophe Tournigand, Pascal Hammel. State of the art and future directions of pancreatic ductal adenocarcinoma therapyPharmacology & Therapeutics 2015; 155: 80 doi: 10.1016/j.pharmthera.2015.08.006
2
Eleni Kotsampasakou, Gerhard F. Ecker. Transporters as Drug TargetsMethods and Principles in Medicinal Chemistry 2017; : 271 doi: 10.1002/9783527679430.ch12
3
C Carbone, G Piro, N Gaianigo, F Ligorio, R Santoro, V Merz, F Simionato, C Zecchetto, G Falco, G Conti, P T Kamga, M Krampera, F Di Nicolantonio, L De Franceschi, A Scarpa, G Tortora, D Melisi. Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttlingInternational Journal of Obesity 2018; 42(3): 334 doi: 10.1038/ijo.2017.285
4
Aleksandra Adamska, Marco Falasca. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?World Journal of Gastroenterology 2018; 24(29): 3222-3238 doi: 10.3748/wjg.v24.i29.3222
5
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic CancerCancers 2017; 9(12): 122 doi: 10.3390/cancers9090122
6
Russell W. Smith, Jeffrey D. Coleman, Jerry T. Thompson, John P. Vanden Heuvel. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cellsBiochemistry and Biophysics Reports 2016; 8: 395 doi: 10.1016/j.bbrep.2016.10.014
7
Wojciech Marlicz, Katarzyna Sielatycka, Karol Serwin, Ewa Kubis, Marta Tkacz, Rafał Głuszko, Andrzej Białek, Teresa Starzyńska, Mariusz Z. Ratajczak. Effect of colorectal cancer on the number of normal stem cells circulating in peripheral bloodOncology Reports 2016; 36(6): 3635 doi: 10.3892/or.2016.5179
8
Lindsay A. Bliss, Mariam F. Eskander, Tara S. Kent, Ammara A. Watkins, Susanna W.L. de Geus, Alessandra Storino, Sing Chau Ng, Mark P. Callery, A. James Moser, Jennifer F. Tseng. Early surgical bypass versus endoscopic stent placement in pancreatic cancerHPB 2016; 18(8): 671 doi: 10.1016/j.hpb.2016.05.008
9
Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsWorld Journal of Gastroenterology 2017; 23(32): 5875-5886 doi: 10.3748/wjg.v23.i32.5875
10
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancerSeminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
11
Carolina Torres, Paul J. Grippo. Pancreatic cancer subtypes: a roadmap for precision medicineAnnals of Medicine 2018; 50(4): 277 doi: 10.1080/07853890.2018.1453168
12
Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic StudyInternational Journal of Molecular Sciences 2019; 20(21): 5250 doi: 10.3390/ijms20215250
13
Ayesha Manzur, Adeolu Oluwasanmi, Darren Moss, Anthony Curtis, Clare Hoskins. Nanotechnologies in Pancreatic Cancer TherapyPharmaceutics 2017; 9(4): 39 doi: 10.3390/pharmaceutics9040039
14
Martin Wartenberg, Irene Centeno, Stefan Haemmig, Erik Vassella, Inti Zlobec, José A. Galván, Maja Neuenschwander, Cornelia Schlup, Beat Gloor, Alessandro Lugli, Aurel Perren, Eva Karamitopoulou. PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potentialEuropean Journal of Cancer 2016; 65: 80 doi: 10.1016/j.ejca.2016.06.013
15
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosisBiochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
16
Isabella Frigerio, Paolo Regi, Alessandro Giardino, Filippo Scopelliti, Roberto Girelli, Claudio Bassi, Stefano Gobbo, Paolo Tinazzi Martini, Paola Capelli, Mirko D’Onofrio, Giuseppe Malleo, Laura Maggino, Elena Viviani, Giovanni Butturini. Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?Annals of Surgical Oncology 2017; 24(8): 2397 doi: 10.1245/s10434-017-5885-4
17
Qing-Hua Liu, Hong-Mei Yong, Qing-Xin Zhuang, Xu-Ping Zhang, Ping-Fu Hou, Yan-Su Chen, Ming-Hua Zhu, Jin Bai. Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancerInvestigational New Drugs 2020; 38(2): 350 doi: 10.1007/s10637-019-00785-5
18
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature ReviewFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
19
Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti. Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic CancerBiomolecules 2021; 11(6): 780 doi: 10.3390/biom11060780
20
Nai-Jung Chiang, Kelvin K. Tsai, Chin-Fu Hsiao, Shih-Hung Yang, Hui-Hua Hsiao, Wen-Chi Shen, Chiun Hsu, Yu-Lin Lin, Jen-Shi Chen, Yan-Shen Shan, Li-Tzong Chen. A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 studyEuropean Journal of Cancer 2020; 124: 123 doi: 10.1016/j.ejca.2019.10.023
21
Nai-Jung Chiang, Jang-Yang Chang, Yan-Shen Shan, Li-Tzong Chen. Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancerExpert Opinion on Pharmacotherapy 2016; 17(10): 1413 doi: 10.1080/14656566.2016.1183646
22
K. Vanova, S. Boukalova, H. Gbelcova, L. Muchova, J. Neuzil, R. Gurlich, T. Ruml, L. Vitek. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cellsBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2343-9
23
Raffaela Santoro, Marco Zanotto, Francesca Simionato, Camilla Zecchetto, Valeria Merz, Chiara Cavallini, Geny Piro, Fabio Sabbadini, Federico Boschi, Aldo Scarpa, Davide Melisi. Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic CancerMolecular Cancer Therapeutics 2020; 19(1): 247 doi: 10.1158/1535-7163.MCT-19-0270
24
Aleksandra Adamska, Riccardo Ferro, Rossano Lattanzio, Emily Capone, Alice Domenichini, Verena Damiani, Giovanna Chiorino, Begum Gokcen Akkaya, Kenneth J. Linton, Vincenzo De Laurenzi, Gianluca Sala, Marco Falasca. ABCC3 is a novel target for the treatment of pancreatic cancerAdvances in Biological Regulation 2019; 73: 100634 doi: 10.1016/j.jbior.2019.04.004
25
Ademar Dantas Cunha Júnior, Arinilda Campos Bragagnoli, Felipe Osório Costa, José Barreto Campello Carvalheira. Repurposing metformin for the treatment of gastrointestinal cancerWorld Journal of Gastroenterology 2021; 27(17): 1883-1904 doi: 10.3748/wjg.v27.i17.1883
26
Ilaria Passacantilli, Valentina Panzeri, Pamela Bielli, Donatella Farini, Emanuela Pilozzi, Gianfranco Delle Fave, Gabriele Capurso, Claudio Sette. Alternative polyadenylation of ZEB1 promotes its translation during genotoxic stress in pancreatic cancer cellsCell Death & Disease 2017; 8(11): e3168 doi: 10.1038/cddis.2017.562
27
Alexandria Turner, Danielle R. Bond, Quan V. Vuong, Anita Chalmers, Emma L. Beckett, Judith Weidenhofer, Christopher J. Scarlett. Elaeocarpus reticulatus fruit extracts reduce viability and induce apoptosis in pancreatic cancer cells in vitroMolecular Biology Reports 2020; 47(3): 2073 doi: 10.1007/s11033-020-05307-8
28
Wenhua Li, Ling Liu, Di Liu, Shimao Jin, Yisha Yang, Wei Tang, Lei Gong. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinomaBiochemical and Biophysical Research Communications 2016; 472(1): 156 doi: 10.1016/j.bbrc.2016.02.087
29
Concetta Panebianco, Edgar Kelman, Kristel Vene, Domenica Gioffreda, Francesca Tavano, Raivo Vilu, Fulvia Terracciano, Illar Pata, Kaarel Adamberg, Angelo Andriulli, Valerio Pazienza. Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancersClinical Chemistry and Laboratory Medicine (CCLM) 2017; 56(1): 138 doi: 10.1515/cclm-2016-1158
30
Bengt Glimelius. Any progress in pancreatic cancer?Acta Oncologica 2016; 55(3): 255 doi: 10.3109/0284186X.2015.1126350
31
Arsheed A. Ganaie, Aijaz Parray, Tabish Hussain, Ashraf Shabaneh, Anmbreen Jamroze, Marina G. Ferrari, Lei Wang, D. Joshua Liao, Shahriar Koochekpour, Sanjeev Nanda, Jinhua Wang, Yibin Deng, Sergio A Gradilone, Edward H. Hinchcliffe, Badrinath R. Konety, Mohammad Saleem. Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease ProgressionTranslational Oncology 2019; 12(8): 1056 doi: 10.1016/j.tranon.2019.05.002
32
Georgios Gemenetzis, Vincent P. Groot, Alex B. Blair, Ding Ding, Sameer S. Thakker, Elliot K. Fishman, John L. Cameron, Martin A. Makary, Matthew J. Weiss, Christopher L. Wolfgang, Jin He. Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinomaJournal of Surgical Oncology 2018; 118(8): 1277 doi: 10.1002/jso.25288
33
Marco Falasca, Minkyoung Kim, Ilaria Casari. Pancreatic cancer: Current research and future directionsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 123 doi: 10.1016/j.bbcan.2016.01.001
34
Chiara Caparello, Laura L Meijer, Ingrid Garajova, Alfredo Falcone, Tessa Y Le Large, Niccola Funel, Geert Kazemier, Godefridus J Peters, Enrico Vasile, Elisa Giovannetti. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerWorld Journal of Gastroenterology 2016; 22(31): 6987-7005 doi: 10.3748/wjg.v22.i31.6987
35
Richard A. Hubner, Antonio Cubillo, Jean-Frédéric Blanc, Davide Melisi, Daniel D. Von Hoff, Andrea Wang-Gillam, Li-Tzong Chen, Claus Becker, Khalid Mamlouk, Bruce Belanger, Yoojung Yang, Floris A. de Jong, Jens T. Siveke. Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinEuropean Journal of Cancer 2019; 106: 24 doi: 10.1016/j.ejca.2018.09.029
36
Francesca Simionato, Camilla Zecchetto, Valeria Merz, Alessandro Cavaliere, Simona Casalino, Marina Gaule, Mirko D’Onofrio, Giuseppe Malleo, Luca Landoni, Alessandro Esposito, Giovanni Marchegiani, Luca Casetti, Massimiliano Tuveri, Salvatore Paiella, Filippo Scopelliti, Alessandro Giardino, Isabella Frigerio, Paolo Regi, Paola Capelli, Stefano Gobbo, Armando Gabbrielli, Laura Bernardoni, Vita Fedele, Irene Rossi, Cristiana Piazzola, Serena Giacomazzi, Martina Pasquato, Morena Gianfortone, Stefano Milleri, Michele Milella, Giovanni Butturini, Roberto Salvia, Claudio Bassi, Davide Melisi. A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trialTherapeutic Advances in Medical Oncology 2020; 12: 175883592094796 doi: 10.1177/1758835920947969
37
Paola Cappello, Elisabetta Tonoli, Roberta Curto, Daniele Giordano, Mirella Giovarelli, Francesco Novelli. Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell responseOncoImmunology 2016; 5(5): e1112940 doi: 10.1080/2162402X.2015.1112940
38
Eunice Eugenia Robless, Justin Andrew Howard, Ilaria Casari, Marco Falasca. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancerCancer Letters 2021; 501: 55 doi: 10.1016/j.canlet.2020.12.005
39
Antonella Argentiero, Angela Calabrese, Angela Monica Sciacovelli, Sabina Delcuratolo, Antonio Giovanni Solimando, Oronzo Brunetti. Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic OptionCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8679751
40
Berna Akkus Yildirim, Yurday Özdemir, Tamer Colakoglu, Erkan Topkan. Impact of presence and degree of pretreatment weight loss in locally-advanced pancreatic cancer patients treated with definitive concurrent chemoradiotherapyPancreatology 2016; 16(4): 599 doi: 10.1016/j.pan.2016.03.006
41
Paola Cappello, Claudia Curcio, Giorgia Mandili, Cecilia Roux, Sara Bulfamante, Francesco Novelli. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersCancers 2018; 10(2): 51 doi: 10.3390/cancers10020051
42
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, Denis Pezet, Gael Deplanque, Martin Fuchs, Jorg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael M. F. Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancerBritish Journal of Cancer 2018; 119(10): 1208 doi: 10.1038/s41416-018-0246-z
43
Haseeb Zubair, Shafquat Azim, Sanjeev Kumar Srivastava, Aamir Ahmad, Arun Bhardwaj, Mohammad Aslam Khan, Girijesh Kumar Patel, Sumit Arora, James Elliot Carter, Seema Singh, Ajay Pratap Singh. Glucose Metabolism Reprogrammed by Overexpression of IKKε Promotes Pancreatic Tumor GrowthCancer Research 2016; 76(24): 7254 doi: 10.1158/0008-5472.CAN-16-1666
44
Roberto Ferrara, Francesca Simionato, Chiara Ciccarese, Elisabetta Grego, Sara Cingarlini, Roberto Iacovelli, Emilio Bria, Giampaolo Tortora, Davide Melisi. The development of PARP as a successful target for cancer therapyExpert Review of Anticancer Therapy 2018; 18(2): 161 doi: 10.1080/14737140.2018.1419870